Synbio Tech Inc. (TPEX:1295)
Taiwan
· Delayed Price · Currency is TWD 57.20
-0.10 (-0.17%)
Apr 29, 2026, 1:30 PM CST
Synbio Tech Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | 175.97 | 170.13 | 113.27 | 92.52 |
| Depreciation & Amortization | 75.85 | 72.48 | 76.88 | 77.27 |
| Other Amortization | 3.38 | 3.57 | - | - |
| Loss (Gain) From Sale of Assets | 0.83 | - | 0.06 | - |
| Stock-Based Compensation | 3.48 | - | - | - |
| Provision & Write-off of Bad Debts | 0.14 | - | - | 0.33 |
| Other Operating Activities | -16.61 | 12.83 | 19.3 | 1.02 |
| Change in Accounts Receivable | -4.77 | -5.01 | -27.04 | 25.21 |
| Change in Inventory | -73.61 | -13.97 | 7.11 | 0.59 |
| Change in Accounts Payable | -9.83 | 5.77 | 7.99 | -9.93 |
| Change in Unearned Revenue | -4.66 | -5.8 | 8.52 | -0.21 |
| Change in Other Net Operating Assets | -6.82 | 21.55 | 7.85 | 0.29 |
| Operating Cash Flow | 143.35 | 261.54 | 213.93 | 187.09 |
| Operating Cash Flow Growth | -45.19% | 22.25% | 14.35% | - |
| Capital Expenditures | -703.07 | -302.15 | -327.29 | -216.63 |
| Sale of Property, Plant & Equipment | 0.09 | - | 0.02 | - |
| Sale (Purchase) of Intangibles | -1.95 | -8.8 | -0.41 | -3.64 |
| Investment in Securities | -134.57 | -1.81 | 190.17 | 16.87 |
| Other Investing Activities | 0.63 | -0.45 | 0.35 | -0.03 |
| Investing Cash Flow | -838.87 | -313.21 | -137.17 | -203.43 |
| Short-Term Debt Issued | 630.01 | 240.63 | - | - |
| Long-Term Debt Issued | - | - | 301.02 | 267.22 |
| Total Debt Issued | 630.01 | 240.63 | 301.02 | 267.22 |
| Short-Term Debt Repaid | - | - | -72.5 | -107.72 |
| Long-Term Debt Repaid | -207.45 | -28.49 | -117.87 | -29.55 |
| Total Debt Repaid | -207.45 | -28.49 | -190.37 | -137.27 |
| Net Debt Issued (Repaid) | 422.56 | 212.14 | 110.64 | 129.95 |
| Issuance of Common Stock | 179.23 | - | - | - |
| Common Dividends Paid | -109.74 | -46.11 | -61.48 | -70.15 |
| Other Financing Activities | 0.15 | - | - | - |
| Financing Cash Flow | 492.2 | 166.03 | 49.16 | 59.8 |
| Foreign Exchange Rate Adjustments | 3.87 | 8.29 | -5.47 | -1.78 |
| Net Cash Flow | -199.45 | 122.65 | 120.46 | 41.68 |
| Free Cash Flow | -559.72 | -40.62 | -113.36 | -29.54 |
| Free Cash Flow Margin | -53.89% | -4.11% | -13.77% | -4.00% |
| Free Cash Flow Per Share | -16.79 | -1.29 | -3.60 | -0.94 |
| Cash Interest Paid | 12.56 | 8.27 | 7.3 | 4.83 |
| Cash Income Tax Paid | 40.13 | 42.75 | 18.41 | 27.27 |
| Levered Free Cash Flow | -656.24 | -52.51 | 37.91 | - |
| Unlevered Free Cash Flow | -648.32 | -50.19 | 42.04 | - |
| Change in Working Capital | -99.69 | 2.54 | 4.43 | 15.95 |
Source: S&P Capital IQ. Standard template. Financial Sources.